Benign neoplasm: Bone and articular cartilage, unspecified

CD2_BENIGN_BONE_CARTILAGE_NOS

bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D16.90&, D16.91& Hospital discharge: ICD-9 — 2139 Hospital discharge: ICD-8 — 2130[8-9] Cause of death: ICD-10 — D16.90&, D16.91& Cause of death: ICD-9 — 2139 Cause of death: ICD-8 — 2130[8-9] 2 out of 7 registries used, show all original rules.	283
4. Check minimum number of events None	283
5. Include endpoints None	283
6. Filter based on genotype QC (FinnGen only)	269

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_BONE_CARTILAGE_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D169
HD_ICD_9	2139
HD_ICD_8	2130[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D169
COD_ICD_9	2139
COD_ICD_8	2130[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Bone and articular cartilage, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2211	1137	1059
Only index persons	1934	1023	911
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.03
Only index persons	0.04	0.04	0.03
Median age at first event (years)
Whole population	35.83	38.19	33.13
Only index persons	33.83	37.05	30.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	269	155	114
Unadjusted period prevalence (%)	0.05	0.05	0.05
Median age at first event (years)	39.21	38.52	40.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
283: Matched controls
2830

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D16.90

ICD-10 Finland

Bone and articular cartilage, unspecified

+∞

197.9

166

21309

ICD-8 Finland

Benign neoplasm of bone and cartilage, Unspecified

+∞

51.7

21308

ICD-8 Finland

Benign neoplasm of bone and cartilage, Loco alio sive multiplici

+∞

38.4

2139X

ICD-9 Finland

Benign neoplasm of bone and articular cartilage, Bone and articular cartilage, site unspecified

+∞

22.2

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

24.7

20.9

AAP10

NOMESCO Finland

Extirpation of a skull lesion

146.8

13.6

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

22.5

13.5

D16.49

ICD-10 Finland

Bones of skull and face

+∞

12.6

9102

FHL

Trepanation or removal of the local bone process

24.1

11.7

D16.1

ICD-10 Finland

Benign neoplasm: Short bones of upper limb

57.0

9.7

D16.9

ICD-10 Finland

Benign neoplasm: Bone and articular cartilage, unspecified

+∞

9.4

D16.2

ICD-10 Finland

Benign neoplasm: Long bones of lower limb

19.4

9.0

D16.91

ICD-10 Finland

Benign tumor in unspecified localization in bone with urpsrung in teeth

+∞

8.4

D16.0

ICD-10 Finland

Benign neoplasm: Scapula and long bones of upper limb

46.3

7.8

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

41.1

6.8

NFR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of hip or thigh

41.1

6.8

1220

FHL

Arthroscopy

3.9

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

396

1.83

4.13

1.4

1.3

5.43

8.56

u/ml

0.28

156

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

413

1.82

4.10

1.5

1.3

55.73

24.88

iu/ml

0.31

137

(3026493) Urate [Moles/volume] in Serum or Plasma

569

1.62

3.21

2.2

2.5

324.97

4854.52

umol/l

2.05

501

(3013826) Glucose [Moles/volume] in Serum or Plasma

157

1275

1.52

3.00

3.6

4.9

6.46

6.58

mmol/l

0.33

141

1182

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

130

1019

1.51

2.92

4.7

7.0

1.22

1.21

mmol/l

0.08

113

864

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

119

928

1.49

2.68

4.0

6.1

1.21

mmol/l

0.03

104

852

(3013139) Helicobacter pylori Ag [Presence] in Stool

136

2.00

2.60

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

254

1.72

2.45

5.7

6.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2.92

2.23

1.8

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

198

1740

1.46

2.21

7.6

7.1

75.16

77.93

u/l

0.52

189

1627

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

4.06

2.05

1.8

1.5

0.83

0.98

g/l

—

(3007853) Bacteria identified in Skin by Aerobe culture

262

1.61

1.95

1.5

1.6

—

(3042936) Bacteria identified in Isolate by Culture

304

1.57

1.94

2.0

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

332

1.54

1.87

1.5

1.3

724.00

514.05

titre

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

251

2343

1.63

1.85

13.7

14.5

3.95

3.97

mmol/l

0.51

244

2275

(3013707) Erythrocyte sedimentation rate by Westergren method

193

1714

1.40

1.84

4.4

3.8

9.64

10.44

mm/h

0.40

179

1576

(3020682) Albumin/Creatinine [Ratio] in Urine

608

1.42

1.80

3.1

3.8

3.50

9.08

mg/mmol

1.89

396

(3019550) Sodium [Moles/volume] in Serum or Plasma

250

2338

1.59

1.75

13.7

14.4

139.57

139.70

mmol/l

0.37

242

2273

(40768804) Tissue Pathology biopsy report

112

920

1.36

1.72

2.1

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

663

1.38

1.64

1.8

2.0

294.39

230.38

u/l

0.29

623

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

248

2323

1.55

1.63

13.4

12.9

20.26

21.55

mg/l

0.28

204

1795

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

229

2117

1.43

1.56

4.7

4.6

1.65

2.41

mu/l

0.75

213

1960

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

195

1758

1.35

1.54

4.0

3.9

14.46

14.62

pmol/l

0.45

177

1604

(3023419) Bacteria identified in Sputum by Culture

2.63

1.52

1.1

2.6

—

(3008898) HLA-B27 [Presence]

110

1.78

1.47

1.1

—

(40768443) Skin Pathology biopsy report

1.85

1.40

1.5

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.45

1.40

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

2.97

1.36

1.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

2.97

1.36

1.2

—

(3019225) pH of Specimen

193

1.56

1.36

1.9

4.6

—

(3044640) Blood type and Crossmatch panel - Blood

703

1.32

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.81

1.29

1.0

1.2

—

(3012516) Albumin [Mass/volume] in Urine

578

1.33

1.24

2.8

3.3

981.61

159.44

mg/l

0.40

384

(3004588) Protein electrophoresis panel - Serum or Plasma

132

1.64

1.24

2.1

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

833

1.29

1.22

2.9

3.5

80.03

39.33

ng/l

0.33

525

(3015377) Calcium [Moles/volume] in Serum or Plasma

723

1.29

1.17

3.1

3.3

2.36

2.35

mmol/l

0.39

653

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

1.17

0.0

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

1.17

0.0

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

1.17

0.0

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

1.17

0.0

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

1.16

0.0

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

112

962

1.27

1.16

10.9

11.6

1.27

1.18

inr

0.41

302

(4146454) Self-monitoring of blood glucose

2.53

1.15

1.2

2.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.03

1.13

1.0

1.5

—

(40768797) Stomach Pathology biopsy report

298

1.40

1.10

1.2

—

(3044889) 12 lead EKG panel

174

1581

1.26

1.10

3.4

3.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

105

901

1.26

1.09

4.4

4.7

36.64

36.14

g/l

0.43

100

855

(3021788) Differential panel - Synovial fluid

2.22

1.09

1.9

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

544

1.30

1.07

2.0

3.2

493.46

1143.64

ng/l

2.68

453

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

518

1.30

1.04

2.2

—

(3002032) Base excess in Venous blood by calculation

172

1.50

1.04

1.9

3.0

1.27

2.12

mmol/l

0.50

136

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.09

1.03

2.4

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

171

1558

1.25

1.02

4.3

3.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.74

1.00

1.0

1.1

—

2.95

—

(21494755) Public health laboratory ask at order entry panel

293

0.66

1.00

1.2

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

131

1163

1.24

0.98

6.2

6.1

12.95

10.86

umol/l

0.49

125

1104

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.95

0.0

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

1.81

0.95

1.0

1.1

—

80.00

—

(3000850) Epithelial cells [#/volume] in Urine

460

1.30

0.95

2.0

2.5

4.85

5.25

e6/l

0.07

416

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

351

1.34

0.95

2.4

2.5

3.82

1.00

e6/l

0.52

192

(40758558) Short blood count panel - Blood

553

1.28

0.94

7.1

6.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.85

0.93

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.85

0.93

1.6

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.70

0.93

2.3

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.17

0.92

2.7

2.1

14.00

13.15

—

(3052851) Hemolysis interference index of Serum or Plasma

1.81

0.89

3.1

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.81

0.89

1.8

2.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

512

1.27

0.87

1.4

1.7

0.66

1.10

mg/l

2.04

396

(3014576) Chloride [Moles/volume] in Serum or Plasma

240

1.38

0.87

4.1

7.2

104.09

104.03

mmol/l

0.03

240

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

104

1.57

0.86

2.8

2.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

163

1.45

0.85

1.7

2.5

74.00

69.03

ml/min/173m2

—

(3026008) Bacteria identified in Urine by Culture

598

1.25

0.85

2.5

2.7

—

(3004616) Nuclear Ab [Presence] in Serum

1.96

0.85

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.89

0.82

1.0

1.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

772

1.22

0.81

2.9

3.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

252

1.35

0.81

1.9

5.5

1.06

1.02

mmol/l

0.57

233

(4062490) Immunoglobulin typing, IgG

0.00

0.79

0.0

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

0.00

0.79

0.0

1.2

—

6.59

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

0.00

0.79

0.0

1.2

—

0.32

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

0.00

0.79

0.0

1.2

—

2.83

—

(3000012) Reticulocyte production index

0.00

0.78

0.0

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

529

1.25

0.78

1.4

1.3

5.11

1.24

u/ml

0.45

138

(4035726) Immunohistochemistry procedure

184

1.39

0.77

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.76

0.0

1.3

—

(40768800) Prostate Pathology biopsy report

1.86

0.74

1.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

329

1.29

0.73

2.5

2.7

4.42

2.54

e6/l

0.66

170

(3045142) Bone marrow Pathology biopsy report

2.02

0.73

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.64

0.72

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1.77

0.72

1.4

1.3

397.97

12.82

u/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

144

0.61

0.71

1.3

1.5

—

(3025941) Bacteria identified in Stool by Culture

127

1.45

0.70

1.2

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.62

0.69

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.62

0.69

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

102

910

1.19

0.69

2.2

73.89

74.29

nmol/l

0.06

821

(3030467) Casts [#/volume] in Urine by Automated count

603

1.21

0.68

2.7

2.9

0.13

0.45

e6/l

1.77

452

(40760892) CBC W Ordered Manual Differential panel - Blood

119

1078

1.18

0.67

6.3

5.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.80

0.66

1.6

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.80

0.66

1.2

1.4

—

nmol/l

—

(3037121) Protein [Mass/volume] in Urine

1.57

0.63

2.2

3.2

0.16

0.19

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

122

1.42

0.61

1.1

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

143

1322

1.17

0.61

9.3

9.0

4.08

4.10

e9/l

0.02

124

1151

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

2.3

—

(3008295) Osmolality of Serum or Plasma

0.00

0.60

0.0

1.7

—

276.33

—

(3017181) Myelocytes/100 leukocytes in Blood

175

1.34

0.60

3.6

4.2

1.00

0.80

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.59

0.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

650

1.19

0.59

2.8

3.1

8.10

7.80

mmol/l

0.18

566

(3013115) Eosinophils [#/volume] in Blood

128

1176

1.16

0.59

6.1

5.7

0.20

0.19

e9/l

0.22

113

1038

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

229

0.73

0.58

3.3

3.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.58

0.0

4.0

—

(3018418) pH of Serum or Plasma

632

1.19

0.58

3.3

3.5

7.40

7.39

—

117

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

231

2224

1.21

0.58

4.0

4.3

5.81

5.89

mmol/l

0.29

212

2055

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

397

1.22

0.56

2.6

2.8

2.45

mmol/l

0.01

350

(3049717) Cytology report of Urine Cyto stain

1.56

0.56

1.9

2.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

238

0.74

0.55

1.9

2.7

1.39

1.75

2.59

218

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

407

1.22

0.55

1.3

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

120

1102

1.15

0.55

6.3

5.2

56.78

57.16

0.12

112

1036

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.59

0.54

1.2

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

233

1.27

0.53

3.1

3.8

370.55

235.11

u/l

0.69

219

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

269

0.76

0.53

1.4

1.8

—

(3018095) Leukocytes [#/volume] in Urine

782

1.16

0.53

3.2

3.5

139.32

67.58

e6/l

0.28

550

(3019309) Folate [Moles/volume] in Red Blood Cells

372

1.22

0.53

1.4

1.6

1089.19

1211.26

nmol/l

0.48

282

(40761511) CBC panel - Blood by Automated count

252

2453

1.25

0.52

12.0

—

(36304419) Bacteria [Presence] in Urine

600

1.18

0.52

2.7

2.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.50

1.2

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

254

1.25

0.49

4.1

4.3

34.09

31.01

0.84

167

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

174

1649

1.14

0.49

3.6

3.1

48.84

46.15

u/l

0.15

166

1556

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

226

2182

1.18

0.49

11.4

11.6

84.27

84.66

ml/min/173m2

0.10

181

1769

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.53

0.48

1.9

1.2

—

(4200892) Spirometry reversibility

174

1.29

0.46

1.4

—

(3025159) Blasts/100 leukocytes in Blood

156

1.30

0.46

4.0

4.3

0.14

0.04

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

848

1.14

0.46

2.0

1.8

97.66

96.40

pmol/l

0.07

438

(3023520) Reticulocytes [#/volume] in Blood

175

0.73

0.46

2.2

2.8

49.86

70.36

e9/l

—

137

(3022313) Gas panel - Capillary blood

1.39

0.44

2.6

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

548

0.85

0.43

4.4

4.0

17.74

21.75

1.44

245

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

140

1.31

0.43

1.4

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

126

1177

1.13

0.43

6.3

5.3

1.99

2.04

e9/l

0.11

114

1050

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.2

—

7.17

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.41

0.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.41

0.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.41

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

116

1081

1.12

0.41

6.3

5.3

2.87

2.79

0.13

109

1012

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.41

0.0

2.2

—

592.35

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

1.13

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.48

0.40

2.6

8.9

—

135.25

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.40

0.0

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

0.00

0.40

0.0

1.9

—

3.56

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1.32

0.40

1.9

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

290

1.20

0.39

2.1

65.76

110.67

ug/g

1.12

239

(3019069) Monocytes/100 leukocytes in Blood

116

1084

1.12

0.39

6.9

5.6

8.45

8.35

0.12

107

1019

(3029937) Albumin [Presence] in Urine by Test strip

615

1.14

0.38

3.4

3.7

0.00

0.01

estimate

0.80

222

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1.40

0.38

1.0

—

2.84

—

(40761536) Microorganisms panel - Urine sediment

202

0.78

0.38

1.7

3.5

—

(3000492) Spirometry study

234

0.80

0.37

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.40

0.37

2.1

1.8

86.00

91.60

—

(3001019) Free T4 and TSH panel - Serum or Plasma

146

0.74

0.37

1.5

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

119

1117

1.11

0.36

6.4

5.4

28.53

28.24

0.11

112

1051

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

0.65

0.36

1.6

1.8

1.88

4.79

ug/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.64

0.36

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

108

1.31

0.36

4.6

14.5

—

(3037756) Immunofixation for Serum or Plasma

1.44

0.36

1.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.44

0.36

1.0

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.40

0.35

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.40

0.35

1.2

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.37

0.34

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

166

1589

1.11

0.34

3.2

3.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

109

1.30

0.34

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

660

0.88

0.33

1.4

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

670

1.12

0.33

2.7

3.0

40.79

54.60

e6/l

0.19

514

(3022096) Basophils/100 leukocytes in Blood

111

1043

1.11

0.33

6.2

5.3

0.65

0.67

0.17

104

970

(3007461) Platelets [#/volume] in Blood

264

2601

1.22

0.32

20.3

18.7

254.03

251.60

e9/l

0.23

259

2550

(3006315) Basophils [#/volume] in Blood

121

1145

1.10

0.31

6.3

5.3

0.04

e9/l

0.35

106

995

(3009542) Hematocrit [Volume Fraction] of Blood

264

2602

1.22

0.30

20.1

18.8

40.48

40.61

0.13

252

2464

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

207

2127

0.90

0.30

5.0

5.2

38.70

39.48

mmol/mol

0.62

195

1996

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

327

1.15

0.29

1.6

1.9

1.40

1.46

0.27

288

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.26

0.29

1.1

1.6

—

(3027944) Amphetamines [Presence] in Urine

108

0.73

0.29

1.8

1.3

—

(3019150) Specific gravity of Urine by Refractometry

491

1.12

0.29

3.8

3.7

1.02

kg/l

—

(3013512) EKG study

598

1.11

0.28

3.5

3.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

328

1.15

0.28

1.3

2.0

—

(3026361) Erythrocytes [#/volume] in Blood

264

2604

1.21

0.28

20.2

18.7

4.55

4.53

e12/l

0.42

257

2545

(3010813) Leukocytes [#/volume] in Blood

264

2604

1.21

0.28

20.2

18.7

6.71

6.67

e9/l

0.09

258

2546

(3007164) IgA [Mass/volume] in Serum or Plasma

482

1.12

0.28

1.3

1.4

2.26

2.43

g/l

0.36

287

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

118

0.75

0.28

2.0

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.24

0.27

1.8

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

692

0.90

0.27

5.1

4.3

1.67

2.07

ug/l

0.72

619

(3001604) Monocytes [#/volume] in Blood

120

1144

1.08

0.25

6.2

5.3

0.57

0.56

e9/l

0.03

104

991

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

887

1.09

0.25

3.3

3.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.19

0.25

1.1

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.28

0.24

1.2

1.3

—

1.90

—

(3035350) Ketones [Presence] in Urine by Test strip

117

1116

1.08

0.24

3.3

3.4

0.04

0.00

estimate

0.49

232

(3021440) Promyelocytes/100 leukocytes in Blood

162

1.19

0.23

4.0

4.3

0.00

0.17

—

(3025130) Human papilloma virus identified in Specimen

1.32

0.23

2.0

1.9

—

(3045424) Erythrocytes [Presence] in Urine

1.32

0.23

1.0

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.32

0.23

3.0

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

125

1.21

0.23

1.1

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.74

0.22

1.3

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1.22

0.22

3.0

3.4

12.60

39.13

u/ml

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

135

1.20

0.22

2.1

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

173

1.17

0.21

2.3

1.8

—

(3017569) Oxygen content in Arterial blood

0.00

0.21

0.0

7.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3012565) Volume of 24 hour Urine

0.00

0.21

0.0

2.8

—

2209.09

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.7

—

92.73

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3034426) Prothrombin time (PT)

0.00

0.21

0.0

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3017704) Immunofixation for Urine

0.00

0.21

0.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.21

0.0

1.5

—

0.22

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.17

0.21

2.2

3.1

—

(36660697) Celiac disease serology panel - Serum

202

1.15

0.21

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

0.00

0.21

0.0

3.1

—

680.50

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

41.13

—

(3004451) EKG impression Narrative

0.00

0.21

0.0

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

520.38

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

280.88

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

492

1.10

0.20

4.0

3.4

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.20

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.20

0.0

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.20

0.0

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.23

0.20

4.2

4.6

—

(3000494) Fungus identified in Specimen by Culture

261

1.12

0.19

1.1

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

233

1.13

0.18

1.3

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

111

1067

1.07

0.18

2.7

2.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.17

0.18

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

584

1.08

0.17

1.8

1.7

1.33

1.43

mmol/l

0.61

499

(3043409) Potassium [Moles/volume] in Arterial blood

1.13

0.17

2.9

3.4

3.79

3.99

mmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.23

0.17

2.6

1.9

—

(3022145) Colonoscopy Study observation

246

0.89

0.17

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

117

1129

1.06

0.17

3.3

3.4

0.00

estimate

-0.00

216

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.16

0.16

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.13

0.16

1.1

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

332

1.10

0.16

1.9

2.1

—

(40761535) Cells panel - Urine sediment

168

1.14

0.16

3.2

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.11

0.16

1.0

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

250

2473

1.09

0.15

11.0

9.5

26.82

25.69

u/l

0.59

240

2393

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

398

0.92

0.15

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

402

1.08

0.15

2.6

3.9

437.45

245.67

ng/l

0.24

311

(3017143) Hepatitis C virus Ab [Presence] in Serum

295

1.10

0.14

1.4

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

236

2332

1.07

0.13

4.7

4.6

2.73

2.79

mmol/l

0.45

218

2167

(3000764) Benzodiazepines [Presence] in Urine

107

0.84

0.13

1.7

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

161

1.13

0.13

3.9

4.2

0.93

0.55

—

(3027008) Opiates [Presence] in Urine

108

0.83

0.13

1.7

1.4

—

(3028300) Cannabinoids [Presence] in Urine

108

0.83

0.13

1.7

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

115

1117

1.05

0.12

4.4

4.6

0.00

estimate

0.50

223

(1002224) Polysomnography panel

123

1.15

0.12

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

516

0.94

0.12

1.5

18.41

21.12

nmol/l

0.79

440

(3019832) Treponema pallidum Ab [Presence] in Serum

271

0.92

0.12

1.6

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

301

1.07

0.09

1.7

2.0

—

(3002256) Pathology report gross observation

282

1.07

0.09

1.6

1.2

—

(3023368) Bacteria identified in Blood by Culture

558

1.05

0.09

3.9

4.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

220

2222

0.96

0.09

3.6

3.8

1.17

1.28

mmol/l

2.29

201

2058

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.09

0.09

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

175

0.91

0.08

1.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

234

1.08

0.08

1.3

2.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.83

0.08

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.78

0.08

1.4

1.5

—

(3020891) Body temperature

1.03

0.08

3.6

4.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

174

0.91

0.08

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

660

1.04

0.07

2.3

3.0

—

(4034850) Laboratory test

1.05

0.07

2.1

10.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.83

0.07

4.1

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.04

0.07

1.7

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.87

0.07

1.8

1.4

—

(3015736) pH of Urine

900

1.03

0.07

3.2

6.00

5.84

—

(3016879) Cocaine [Presence] in Urine

101

0.89

0.06

1.7

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

464

1.04

0.06

1.3

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

232

2304

1.04

0.06

4.2

4.63

4.70

mmol/l

0.41

209

2156

(3000330) Specific gravity of Urine by Test strip

1.12

0.05

3.6

3.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

228

2295

0.97

0.05

4.0

4.1

1.49

1.46

mmol/l

0.52

208

2137

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

110

0.91

0.05

1.1

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

268

1.05

0.05

1.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

251

1.04

0.02

1.6

—

(3009343) pH of Capillary blood

132

1.06

0.02

2.5

3.0

—

7.42

—

(1761868) Lipid panel - Serum or Plasma

921

0.98

0.02

2.2

2.7

—

(3021589) Normoblasts [#/volume] in Blood

103

1019

1.02

0.02

8.2

8.7

0.00

e9/l

1.38

822

(3022621) pH of Urine by Test strip

137

0.95

0.01

2.5

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

205

2042

1.01

0.01

16.7

15.5

15.18

14.70

0.50

200

2017

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

122

0.98

0.00

7.1

9.7

0.68

0.70

0.09

122

(3000991) Gas panel - Venous blood

152

0.99

0.00

5.9

8.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

402

0.99

0.00

3.0

2.8

1.25

0.75

ug/l

0.35

240

(46235355) HIV 1 and 2 tests - Meaningful Use set

482

1.00

0.00

1.8

1.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

123

0.97

0.00

7.1

9.5

1.94

1.53

0.66

123

(3019060) Gas panel - Arterial blood

137

1.02

0.00

3.4

7.6

—

(3003396) Base excess in Arterial blood by calculation

224

0.98

0.00

5.5

10.4

1.18

1.49

mmol/l

0.15

181

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.1

—

21.00

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.1

—

57.71

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.0

7.9

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

16.61

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1484.40

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.00

-0.00

1.5

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.98

-0.00

3.3

3.0

52.33

488.51

u/ml

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.8

2.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.88

-0.00

2.6

1.8

134.20

243.25

pmol/l

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

29.94

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.6

—

156.69

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

-0.00

0.0

1.0

—

6.80

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

5.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.91

-0.00

1.6

1.3

—

44.76

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

6.8

—

39.67

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(40768446) Kidney Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3011288) Drugs identified in Urine by Screen method

1.00

-0.00

2.5

1.7

—

(3045414) Leukocytes [Presence] in Urine

0.97

-0.00

1.3

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

0.89

-0.00

1.0

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.00

-0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

-0.00

0.0

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

2.8

—

(40768793) Breast Pathology biopsy report

0.91

-0.00

1.3

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3024932) HLA-DR beta [Type]

0.00

-0.00

0.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.00

-0.00

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.2

—

1.20

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BONE_CARTILAGE_NOS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_CARTILAGE_NOS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BONE_CARTILAGE_NOS – Benign neoplasm: Bone and articular cartilage, unspecified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Bone and articular cartilage, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints